Global Pediatric Growth Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pediatric Growth Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Growth hormones deficiency is a rare condition but it mainly affects the children. The recombinant form of a growth hormone called somatotropin is generally prescribed to treat pediatric patients with growth hormone deficiency. Somatotropin or growth hormone injections are prescribed for pediatric patients with turner syndrome, short stature, Prader-Willi syndrome, Noonan syndrome and other disorders.
Global Pediatric Growth Hormone market is projected to reach US$ 4690 million in 2029, increasing from US$ 3300 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The global pediatric growth hormone market refers to the market for medications and therapies used to treat growth hormone deficiency (GHD) and related disorders in children. Growth hormone is an important hormone produced by the pituitary gland that plays a crucial role in regulating growth, development, and metabolism.
Pediatric growth hormone deficiency can occur due to various factors, including genetic conditions, congenital anomalies, brain injuries, and certain medical treatments. Treatment with growth hormone therapy aims to stimulate growth and development in children who have insufficient or inadequate production of growth hormone.
The global market for pediatric growth hormone is primarily driven by factors such as the increasing prevalence of growth hormone deficiency, rising awareness about the benefits of growth hormone therapy, advances in treatment options, and improving healthcare infrastructure.
Growth hormone therapy for children with growth hormone deficiency involves the subcutaneous administration of synthetic growth hormone on a daily basis. The therapy is typically initiated during childhood and continued until the patient reaches adult height or the maximum growth potential is achieved.
Geographically, North America and Europe hold a significant share in the global pediatric growth hormone market due to the well-established healthcare systems, high awareness levels, and the presence of key market players. The Asia Pacific region is also expected to witness significant growth due to the increasing prevalence of growth hormone deficiency and improving healthcare infrastructure.
Key pharmaceutical companies involved in the production and distribution of pediatric growth hormone products include Novo Nordisk, Pfizer, Eli Lilly and Company, Merck & Co., and Ferring Pharmaceuticals, among others. These companies are focused on developing advanced growth hormone formulations, conducting clinical trials, and expanding their product portfolios to address the specific needs of pediatric patients.
It’s important to note that the pediatric growth hormone market is regulated, and treatment decisions are made based on the diagnosis and guidance of healthcare professionals specializing in pediatric endocrinology. Proper assessment, diagnosis, and monitoring of the child’s growth and hormone levels are essential for safe and effective treatment.
In summary, the global pediatric growth hormone market is driven by factors such as the increasing prevalence of growth hormone deficiency, advances in treatment options, and improving healthcare infrastructure. The market is expected to witness steady growth as awareness about growth hormone therapy increases and healthcare providers continue to diagnose and treat pediatric patients with growth hormone deficiency.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH
Ipsen Biopharmaceuticals
Teva Pharmaceuticals
Anhui Anke Biotechnology (Group) Co., Ltd.
LG Chem
GeneScience Pharmaceuticals Co., Ltd.
Ascendis Pharma A/S
Changchun High & New Tech Industry Inc
Segment by Type
Growth Hormone Deficiency
Turner Syndrome
Prader-Willi Syndrome
Noonan Syndrome
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pediatric Growth Hormone market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pediatric Growth Hormone introduction, etc. Pediatric Growth Hormone Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pediatric Growth Hormone market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Pediatric Growth Hormone market is projected to reach US$ 4690 million in 2029, increasing from US$ 3300 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The global pediatric growth hormone market refers to the market for medications and therapies used to treat growth hormone deficiency (GHD) and related disorders in children. Growth hormone is an important hormone produced by the pituitary gland that plays a crucial role in regulating growth, development, and metabolism.
Pediatric growth hormone deficiency can occur due to various factors, including genetic conditions, congenital anomalies, brain injuries, and certain medical treatments. Treatment with growth hormone therapy aims to stimulate growth and development in children who have insufficient or inadequate production of growth hormone.
The global market for pediatric growth hormone is primarily driven by factors such as the increasing prevalence of growth hormone deficiency, rising awareness about the benefits of growth hormone therapy, advances in treatment options, and improving healthcare infrastructure.
Growth hormone therapy for children with growth hormone deficiency involves the subcutaneous administration of synthetic growth hormone on a daily basis. The therapy is typically initiated during childhood and continued until the patient reaches adult height or the maximum growth potential is achieved.
Geographically, North America and Europe hold a significant share in the global pediatric growth hormone market due to the well-established healthcare systems, high awareness levels, and the presence of key market players. The Asia Pacific region is also expected to witness significant growth due to the increasing prevalence of growth hormone deficiency and improving healthcare infrastructure.
Key pharmaceutical companies involved in the production and distribution of pediatric growth hormone products include Novo Nordisk, Pfizer, Eli Lilly and Company, Merck & Co., and Ferring Pharmaceuticals, among others. These companies are focused on developing advanced growth hormone formulations, conducting clinical trials, and expanding their product portfolios to address the specific needs of pediatric patients.
It’s important to note that the pediatric growth hormone market is regulated, and treatment decisions are made based on the diagnosis and guidance of healthcare professionals specializing in pediatric endocrinology. Proper assessment, diagnosis, and monitoring of the child’s growth and hormone levels are essential for safe and effective treatment.
In summary, the global pediatric growth hormone market is driven by factors such as the increasing prevalence of growth hormone deficiency, advances in treatment options, and improving healthcare infrastructure. The market is expected to witness steady growth as awareness about growth hormone therapy increases and healthcare providers continue to diagnose and treat pediatric patients with growth hormone deficiency.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH
Ipsen Biopharmaceuticals
Teva Pharmaceuticals
Anhui Anke Biotechnology (Group) Co., Ltd.
LG Chem
GeneScience Pharmaceuticals Co., Ltd.
Ascendis Pharma A/S
Changchun High & New Tech Industry Inc
Segment by Type
Growth Hormone Deficiency
Turner Syndrome
Prader-Willi Syndrome
Noonan Syndrome
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pediatric Growth Hormone market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pediatric Growth Hormone introduction, etc. Pediatric Growth Hormone Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pediatric Growth Hormone market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices